| Typicality: | 0.334 |
| Saliency: | 0.198 |
| for the treatment of respiratory infections | 3 | purpose |
| ciprofloxacin → be approved by → the fda | 3 |
| ciprofloxacin → be approved by → regulatory authorities | 3 |
| negative | neutral | positive |
| 0.368 | 0.412 | 0.219 |
| Raw frequency | 6 |
| Normalized frequency | 0.198 |
| Modifier score | 0.500 |
| Perplexity | 11.052 |